Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study.
Wasehuus V, Rotbain Curovic V, Tofte N, Lindhardt M, Currie G, Delles C, Frimodt-Møller M, Mischak H, von der Leyen H, Hansen TW, Kümler T, Persson F, Rossing P; PRIORITY Study group. Wasehuus V, et al. Among authors: tofte n. Diabetes Obes Metab. 2024 Oct 28. doi: 10.1111/dom.16037. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39468380
The associations between functional vitamin K status and all-cause mortality, cardiovascular disease and end-stage kidney disease in persons with type 1 diabetes.
Friis Bryde Nielsen C, Møller Thysen S, Bach Kampmann F, Hansen TW, Jørgensen NR, Tofte N, Abitz Winther S, Theilade S, Rossing P, Frimodt-Møller M, Linneberg A. Friis Bryde Nielsen C, et al. Among authors: tofte n. Diabetes Obes Metab. 2024 Oct 21. doi: 10.1111/dom.16025. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39434445
Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in type 2 diabetes with no history of clinical cardiovascular disease.
Ferreira-Divino LF, Poulsen CG, Rotbain Curovic V, Pedersen OB, Tofte N, Frimodt-Møller M, Hansen TW, Hvas AM, Rossing P. Ferreira-Divino LF, et al. Among authors: tofte n. J Diabetes Complications. 2024 Nov;38(11):108879. doi: 10.1016/j.jdiacomp.2024.108879. Epub 2024 Oct 9. J Diabetes Complications. 2024. PMID: 39405782
Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes.
Rotbain Curovic V, Sørland BA, Hansen TW, Jain SY, Sulek K, Mattila IM, Frimodt-Moller M, Trost K, Legido-Quigley C, Theilade S, Tofte N, Winther SA, Hansen CS, Rossing P, Ahluwalia TS. Rotbain Curovic V, et al. Among authors: tofte n. BMJ Open Diabetes Res Care. 2024 Apr 11;12(2):e003973. doi: 10.1136/bmjdrc-2023-003973. BMJ Open Diabetes Res Care. 2024. PMID: 38604732 Free PMC article.
Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trial.
Rotbain Curovic V, Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Hansen TW, Havrdova T, Kooy A, Laverman GD, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Petrie JR, Ruggenenti PL, Rutters F, Rychlík I, Siwy J, Spasovski G, Speeckaert M, Trillini M, Zürbig P, von der Leyen H, Rossing P; on the behalf of the PRIORITY Study Group. Rotbain Curovic V, et al. Among authors: tofte n. J Diabetes Complications. 2023 Apr;37(4):108433. doi: 10.1016/j.jdiacomp.2023.108433. Epub 2023 Feb 18. J Diabetes Complications. 2023. PMID: 36841085 Clinical Trial.
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes.
Khurana I, Kaipananickal H, Maxwell S, Birkelund S, Syreeni A, Forsblom C, Okabe J, Ziemann M, Kaspi A, Rafehi H, Jørgensen A, Al-Hasani K, Thomas MC, Jiang G, Luk AO, Lee HM, Huang Y, Thewjitcharoen Y, Nakasatien S, Himathongkam T, Fogarty C, Njeim R, Eid A, Hansen TW, Tofte N, Ottesen EC, Ma RC, Chan JC, Cooper ME, Rossing P, Groop PH, El-Osta A. Khurana I, et al. Among authors: tofte n. J Clin Invest. 2023 Feb 15;133(4):e160959. doi: 10.1172/JCI160959. J Clin Invest. 2023. PMID: 36633903 Free PMC article.
Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes.
Ferreira-Divino LF, Suvitaival T, Rotbain Curovic V, Tofte N, Trošt K, Mattila IM, Theilade S, Winther SA, Hansen TW, Frimodt-Møller M, Legido-Quigley C, Rossing P. Ferreira-Divino LF, et al. Among authors: tofte n. Cardiovasc Diabetol. 2022 Jul 18;21(1):135. doi: 10.1186/s12933-022-01568-8. Cardiovasc Diabetol. 2022. PMID: 35850688 Free PMC article.
27 results